TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 788890

Group type: EXPERIMENTAL
Intervention: Intermittent oral cyclophosphamide
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Proposed staging system
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Peripheral lymphocyte count
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Primary tumor site
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Regional node involvement
Number of subjects: 113
Study: 30923036

Group type: EXPERIMENTAL
Intervention: Nivolumab/ipilimumab combination therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-CTLA-4 (ipilimumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-PD-1 therapies (nivolumab, pembrolizumab)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 27832248

Group type: EXPERIMENTAL
Intervention: Binocular game treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patching treatment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Binocular game treatment (after crossover)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patching treatment (after crossover)
Number of subjects: 28
Study: 24077833

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES 130 kDa/0.4)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ringer’s acetate (RAC)
Number of subjects: 30
Study: 22448010

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 1291

Group type: COMPARATOR
Intervention: HIV-infected individuals
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: Lower CD4 count
Number of subjects: 1291

Group type: EXPERIMENTAL
Intervention: Younger age and HCV infection
Number of subjects: 1291
Study: 19915859

Group type: EXPERIMENTAL
Intervention: High intensity interval exercise (HIIE) mode A
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High intensity interval exercise (HIIE) mode C
Number of subjects: 19
Study: 18042304

Group type: EXPERIMENTAL
Intervention: Nicotine (1 mg via nasal spray)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High tense arousal (exposed to hard anagrams)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nicotine and high tense arousal combined
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (matched to nicotine)
Number of subjects: 47
Study: 16163915

Group type: EXPERIMENTAL
Intervention: Propofol-alfentanil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 30
Study: 14607201

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 26
Study: 10372240

Group type: EXPERIMENTAL
Intervention: Troglitazone (400 mg/day) for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glibenclamide (1.25-7.5 mg/day) with diet therapy
Number of subjects: 30
Study: 1932613

Group type: EXPERIMENTAL
Intervention: Diltiazem (DTZ) alone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Diltiazem (DTZ) in combination with Propranolol (PPL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol (PPL) alone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propranolol (PPL) in combination with Diltiazem (DTZ)
Number of subjects: 14
Study: 6853404

Group type: EXPERIMENTAL
Intervention: Temocillin administered intravenously
Number of subjects: 16
Study: 30539221

Group type: EXPERIMENTAL
Intervention: Freehand patellar resection technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cutting guide patellar resection technique
Number of subjects: 100
Study: 30360820

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1660

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1660
Study: 26767506

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 53

Group type: COMPARATOR
Intervention: Massage
Number of subjects: 53
Study: 24485497

Group type: EXPERIMENTAL
Intervention: 10mg hydrocortisone 240 min before delay and trace acquisition (slow cort)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 10mg hydrocortisone 60 min before delay and trace acquisition (rapid cort)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo at both times
Number of subjects: 63
Study: 23012931

Group type: EXPERIMENTAL
Intervention: Bismuth Subgallate/Borneol (Suile) dressing (BSB group, n = 25)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intrasite gel (IG group, n = 10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Bismuth Subgallate/Borneol (Suile) dressing (BSB group)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intrasite gel (IG group)
Number of subjects: 35
Study: 19879724

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard technique
Number of subjects: 44
Study: 17338899

Group type: EXPERIMENTAL
Intervention: Once-daily budesonide (800 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice-daily budesonide (400 microg)
Number of subjects: 0
Study: 16294343

Group type: EXPERIMENTAL
Intervention: Counseling intervention (4 sessions attended together or by the man alone)
Number of subjects: 84
Study: 12234308

Group type: EXPERIMENTAL
Intervention: L-arginine (2.5 g/m(2) or 5 g/m(2) x 3/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9820258

Group type: EXPERIMENTAL
Intervention: Spinal manipulation therapy and soft tissue therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo laser treatment and soft tissue therapy
Number of subjects: 75
Study: 8819662

Group type: EXPERIMENTAL
Intervention: Code A (novel time release preparation of ferrous sulphate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Code B (sustained release ferrous sulphate preparation)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Code A
Number of subjects: 60

Group type: COMPARATOR
Intervention: Code B
Number of subjects: 60
Study: 1663261

Group type: EXPERIMENTAL
Intervention: WC3 rotavirus vaccine (two doses at 1-month interval, first dose at 3 months of age)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Placebo (two doses at 1-month interval, first dose at 3 months of age)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: WC3 rotavirus vaccine
Number of subjects: 472
Study: 7291955

Group type: EXPERIMENTAL
Intervention: Osmic acid
Number of subjects: 126

Group type: COMPARATOR
Intervention: Yttrium-90
Number of subjects: 126
Study: 31629718

Group type: EXPERIMENTAL
Intervention: Mindful eating (attending to the sensory properties of food)
Number of subjects: 60
Study: 30111193

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy
Number of subjects: 51
Study: 27811319

Group type: EXPERIMENTAL
Intervention: MVC alone
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: MVC plus emtricitabine (FTC)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: MVC plus tenofovir disoproxil fumarate (TDF)
Number of subjects: 406

Group type: COMPARATOR
Intervention: TDF plus FTC
Number of subjects: 406
Study: 27657193

Group type: EXPERIMENTAL
Intervention: Ejaculation < 3 days before MRI (Group 1)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Ejaculation ≥ 3 days before MRI (Group 2)
Number of subjects: 238
Study: 25424299

Group type: EXPERIMENTAL
Intervention: Low-intensity pulse ultrasound stimulation (LIPUS) treatment 15 min/day
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (immobilized by plaster support and cast)
Number of subjects: 81
Study: 21617191

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 74
Study: 18839137

Group type: EXPERIMENTAL
Intervention: Right ventricular failure (RVF) present in patients with ARDS
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Patients with RVF (RVF+)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Patients without RVF (RVF-)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Tidal volume in RVF+ patients
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: I/E ratio in RVF+ patients
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Plateau pressure in RVF+ patients
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Multivariate analysis factors associated with day-90 mortality
Number of subjects: 145
Study: 18090188

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 124

Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both groups (partners of patients with antiarrhythmic drugs and implantable cardioverter defibrillator)
Number of subjects: 124
Study: 15347634

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg orally twice daily for 3 days
Number of subjects: 455

Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole 160/800 mg orally twice daily for 7 days
Number of subjects: 455

Group type: COMPARATOR
Intervention: Norfloxacin 400 mg orally twice daily for 7 days
Number of subjects: 455
Study: 11174282

Group type: EXPERIMENTAL
Intervention: Hemoclips (HC)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Heat probe (HP)
Number of subjects: 113
Study: 9821477

Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg o.d. for 4 weeks
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 257
Study: 8031419

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg bolus)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: CRH (100 micrograms bolus)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methoxamine (6 micrograms/kg per min over 3 h)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methoxamine plus CRH
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Naloxone plus CRH
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methoxamine plus naloxone
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 7
Study: 1969244

Group type: EXPERIMENTAL
Intervention: Clonazepam treatment
Number of subjects: 19
Study: 432800

Group type: EXPERIMENTAL
Intervention: Filtered fluids
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Heparin-hydrocortisone combinations
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 266
Study: 30900422

Group type: EXPERIMENTAL
Intervention: Unilateral groin puncture-single trans-septal ablation (UG-ST)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Bilateral groin puncture-double trans-septal ablation (BG-DT)
Number of subjects: 222
Study: 27669638

Group type: EXPERIMENTAL
Intervention: Probiotic capsule
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25511816

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cognitive function tests
Number of subjects: 150
Study: 23490388

Group type: EXPERIMENTAL
Intervention: Telbivudine treatment for 4 years
Number of subjects: 596
Study: 21232155

Group type: EXPERIMENTAL
Intervention: Nicotine-free cigarettes (Quest 3) for six weeks + NRT patches, gum and/or lozenges for eight weeks
Number of subjects: 1410

Group type: COMPARATOR
Intervention: NRT patches, gum and/or lozenges for eight weeks
Number of subjects: 1410
Study: 19597362

Group type: EXPERIMENTAL
Intervention: Trauma-focused group therapy
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Present-focused group therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 166
Study: 17191036

Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 0.25% cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 0.5% cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 1.0% cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrogalen cream (hydrocortisone 1.0%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soventol hydrocortisone (hydrocortisone acetate 0.25%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hydroderm HC 0.5% cream (hydrocortisone 0.5%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (vehicle of test preparations)
Number of subjects: 20
Study: 15471835

Group type: EXPERIMENTAL
Intervention: 123I‐labeled N‐(3‐iodopropene‐2‐yl)‐2beta‐carbomethoxy‐3beta‐(4‐chlorophenyl) tropane and SPECT
Number of subjects: 6
Study: 11450886

Group type: EXPERIMENTAL
Intervention: Oral cefixime 8 mg/kg/day for 10 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Initial intramuscular ceftizoxime 50 mg/kg twice a day for 2 days followed by oral cefixime for 8 days
Number of subjects: 54
Study: 9931851

Group type: EXPERIMENTAL
Intervention: Adjuvant 3-week intravenous PGE1 treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8128173

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN), 2.6 mg, administered 2 hours before ingestion of 500 ml meat soup
Number of subjects: 10

Group type: COMPARATOR
Intervention: No drug administration (Control)
Number of subjects: 10
Study: 2644815

Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate (0.6 mg/kg per day in 4 doses for 4 days)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 49472

Group type: EXPERIMENTAL
Intervention: Carrying a 15 kg weight in a shopping basket
Number of subjects: 13

Group type: COMPARATOR
Intervention: Carrying a 15 kg weight in a rucksack on the back
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sustained handgrip test
Number of subjects: 13
Study: 30691471

Group type: EXPERIMENTAL
Intervention: Vienna Food Record
Number of subjects: 35

Group type: COMPARATOR
Intervention: Weighed food record
Number of subjects: 35
Study: 28121648

Group type: EXPERIMENTAL
Intervention: Oral synbiotic (Lactobacillus plantarum and fructo‐oligosaccharides) administered daily for 7 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no synbiotic treatment)
Number of subjects: 11
Study: 25841588

Group type: EXPERIMENTAL
Intervention: Eating Attitudes Test‐26 (EAT‐26)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Questionnaire of Eating and Weight Patterns–Revised (QEWP‐R)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Comparison of patients with BED vs those without BED
Number of subjects: 320

Group type: COMPARATOR
Intervention: Hospital admissions related to T2DM or any other condition
Number of subjects: 320
Study: 23784076

Group type: EXPERIMENTAL
Intervention: Printed intervention
Number of subjects: 935

Group type: COMPARATOR
Intervention: Web-based intervention
Number of subjects: 935

Group type: EXPERIMENTAL
Intervention: Environmental intervention components
Number of subjects: 935

Group type: COMPARATOR
Intervention: Basic intervention components
Number of subjects: 935
Study: 21183937

Group type: COMPARATOR
Intervention: diet only
Number of subjects: 126

Group type: COMPARATOR
Intervention: diet + aerobic training
Number of subjects: 126

Group type: COMPARATOR
Intervention: diet + resistance training
Number of subjects: 126
Study: 19933787

Group type: EXPERIMENTAL
Intervention: Unsigned statement
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Opinion leader statement
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control
Number of subjects: 480
Study: 16730718

Group type: EXPERIMENTAL
Intervention: Day 2 embryo transfer (ET)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Day 3 embryo transfer (ET)
Number of subjects: 242
Study: 15585899

Group type: EXPERIMENTAL
Intervention: Bimanual task condition
Number of subjects: 94

Group type: COMPARATOR
Intervention: Unimanual task condition
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Adults and elderly
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Developmental trend
Number of subjects: 94
Study: 11748512

Group type: EXPERIMENTAL
Intervention: Anesthesiology residents
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Anesthesiology attending physicians
Number of subjects: 61

Group type: COMPARATOR
Intervention: Radiology residents (control group)
Number of subjects: 61
Study: 9408711

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8123399

Group type: EXPERIMENTAL
Intervention: diclofenac 75 mg i.m. 20 min before operation
Number of subjects: 34

Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 34
Study: 3572036

Group type: EXPERIMENTAL
Intervention: Abbreviated course of doxycycline (until afebrile plus one day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: One-week regimen of doxycycline
Number of subjects: 50
Study: 29459111

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 62
Study: 27900707

Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided biodegradable spacer implantation (InSpace™ system) under local anesthesia
Number of subjects: 15
Study: 24105106

Group type: EXPERIMENTAL
Intervention: Triflusal (300, 600, 900 mg single doses; 600 mg once daily for 7 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HTB (metabolite of Triflusal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triflusal (multiple doses of 600 mg once daily for 7 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triflusal and HTB (pharmacokinetics)
Number of subjects: 30
Study: 23896185

Group type: EXPERIMENTAL
Intervention: Flow restrictors (FRs) added to liquid medicine bottles
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control bottles without FRs (open and incompletely closed)
Number of subjects: 110
Study: 20865678

Group type: EXPERIMENTAL
Intervention: Aerobic training, 3 times a week, at 60-80% of maximal heart rate for 6 weeks (Ex, n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (n = 32)
Number of subjects: 64
Study: 18053662

Group type: EXPERIMENTAL
Intervention: DMPC/DHPC bicelles (molar ratio 2/1)
Number of subjects: 0
Study: 15902852

Group type: EXPERIMENTAL
Intervention: Fixed-bearing posterior-stabilized prosthesis (LPS)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Meniscal-bearing prosthesis (MBK)
Number of subjects: 210
Study: 12488375

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 26
Study: 10675181

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other trials (not adequately randomised)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Swedish meta-analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mammography screening (biennially for 12 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Swedish trials (excluding Malmo trial)
Number of subjects: 0
Study: 9148318

Group type: EXPERIMENTAL
Intervention: Attractive target
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Unattractive target
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Male target
Number of subjects: 176

Group type: COMPARATOR
Intervention: Female target
Number of subjects: 176
Study: 1536156

Group type: EXPERIMENTAL
Intervention: Halon 1211 (1,000 ppm) during exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6531968

Group type: EXPERIMENTAL
Intervention: RA27/3 vaccine strain
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: BRD‐2 vaccine strain
Number of subjects: 98

Group type: COMPARATOR
Intervention: Uninoculated group
Number of subjects: 98
Study: 30756142

Group type: EXPERIMENTAL
Intervention: 20 ml of anaesthetic solution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 30 ml anaesthetic solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 30095289

Group type: EXPERIMENTAL
Intervention: Baska FESS mask
Number of subjects: 100

Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 100
Study: 27350371

Group type: EXPERIMENTAL
Intervention: 'Stand still ..., and move on' intervention
Number of subjects: 185

Group type: COMPARATOR
Intervention: Care-as-usual (Control)
Number of subjects: 185
Study: 25222285

Group type: EXPERIMENTAL
Intervention: GO2KA1 supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22773741

Group type: EXPERIMENTAL
Intervention: ceftolozane/tazobactam 1.5 g administered every 8 h via a 60 min infusion
Number of subjects: 51

Group type: COMPARATOR
Intervention: piperacillin/tazobactam 4.5 g administered every 6 h via a 30 min infusion
Number of subjects: 51
Study: 20186971

Group type: EXPERIMENTAL
Intervention: Therapeutic massage
Number of subjects: 68

Group type: COMPARATOR
Intervention: Thermotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Relaxing room therapy
Number of subjects: 68
Study: 17413956

Group type: EXPERIMENTAL
Intervention: 1.0% carboxymethylcellulose (CMC) mid-viscosity artificial tear
Number of subjects: 607

Group type: COMPARATOR
Intervention: Low-viscosity tears
Number of subjects: 607
Study: 17044658

Group type: EXPERIMENTAL
Intervention: Informed consent process by physicians
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Information sufficiency on the informed consent sheet
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Influence of relatives and friends on patient decision
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Targeting patients for informed consent
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Incentives for patients
Number of subjects: 448
Study: 14557564

Group type: EXPERIMENTAL
Intervention: 30 U Botulinum toxin type A (BTXA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pure saline (placebo)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Capsaicin administered on day 28
Number of subjects: 16
Study: 11039685

Group type: EXPERIMENTAL
Intervention: Conjoint Family Therapy (CFT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Separated Family Therapy (SFT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both CFT and SFT
Number of subjects: 40
Study: 8697144

Group type: EXPERIMENTAL
Intervention: Interferon therapy (IFN-alpha and IFN-gamma)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Busulfan (BU) therapy
Number of subjects: 25